Therapy Center of Excellence

The Therapy Center of Excellence is dedicated to all aspects of the development and utilization of Targeted Radioisotope Therapy (TRT) as an alternative to other treatments. The Therapy Center is creating a multi-disciplinary interest group to share ideas, develop education offerings and advance the utilization of radionuclide therapy.

Mission

The Therapy Center of Excellence is an organizational component within the SNMMI dedicated to all aspects of the development and utilization of Targeted Radioisotope Therapy as an alternative to other treatments. Specifically, the new center will bring together a centralized group of all constituents within this area creating a multi-disciplinary interest group whereby industry, big pharma, physicians, scientists, government and regulatory agencies as well as other stakeholders can convene to share ideas, develop education offerings and advance the utilization of radionuclide therapy. 

The Therapy Center of Excellence:

(a)  Provides a forum for members with similar interests

(b)  Provides expertise in TRT

(c)  Fosters research and education in TRT

(d)  Provides outreach to other professionals and organizations

(e)  Nurtures new membership in SNMMI

 

Overview of Proposed Center of Excellence Activities

The center will focus on several initiatives, specific to the SNMMI Strategic Plan Goal C: Increase Appropriate Utilization of Radionuclide Therapy within the first year:

    Objective 1: Assist in the Development of Emerging Agents.

    Objective 2: Advocacy for Regulatory Approval and Reimbursement of Emerging Agents.

    Objective 3: Advanced the Use of Approved Agents.

 

 

Coming Soon!

The Saul Hertz, MD Award
SNMMI has established The Dr. Saul Hertz Lifetime Achievement Award in honor of the professional achievements of Dr. Hertz as the pioneer of Radioiodine Therapy. The award recognizes individuals who have made outstanding contributions to radionuclide therapy.

2018 Saul Hertz, MD Award Winner

2017 Saul Hertz, MD Award Winner

2016 Saul Hertz, MD Award Winner

 

Therapy Center of Excellence Young Investigator Awards

The Therapy Center of Excellence is pleased to offer the Young Investigator Awards (YIAs) which are supported by grants from the Education and Research Foundation for Nuclear Medicine and Molecular Imaging (ERF). 

2018 Young Investigator Awards

2017 Young Investigator Awards

2016 Young Investigator Awards

SNMMI 2019 Mid-Winter Meeting

Save the date for the 2019 SNMMI Mid-Winter and ACNM Annual Meeting, January 17-19 in Palm Springs, California. The small, focused meeting environment and tailored learning approach will provide you with an ideal setting to further develop relevant skills and maximize tangible outcomes for your practice.

 

Therapy Center Sponsored Sessions at the SNMMI 2018 Annual Meeting

CE43: Saul Hertz Award Symposium: Emerging Theranostic Targets

CE50: Liver Directed Therapy

CAT 1: Radioiodine Theragnostics - Continuing the Update of the Controversies of the Management of Differentiated Thyroid Cancer

CAT 3: PSMA Radioligand Therapy (PRLT) of End-Stage Prostate Cancer Patients Selected by PSMA PET/CT. The Power of Precision Oncology

CE08: Theranostics and Bone Targeting Radiopharmaceutical Therapy in Prostate Cancer

CE15: Differentiated Thyroid Cancer Theranostics Practicum (SAM)

CE22: Alpha-Emitting Radiopharmaceuticals

CE57: Theranostics of Neuroendocrine Tumors: PRRT

 

Therapy Center Sponsored Sessions at the SNMMI 2017 Annual Meeting

CAT1: Update and Controversies in Radioiodine Theranostics

CE09: Saul Hertz Award Symposium and Therapy Center of Excellence Business Meeting

SS15: Therapy Center of Excellence Young Investigator Award Symposium

CE37: Prostate Cancer Theranostics: An Update on Recent Developments, Especially in Dealing with mCRPC (sponsored with WARMTH)

CE51: Myths in Radioiodine Theranostics of Differentiated Thyroid Cancer (sponsored with GCNMC)

CE88: Radioiodine Therapy for Hyperthyroidism: The State of the Art (sponsored with GCNMC)

CE93: Maximal Tolerated Activity of Radioactive Iodine for Metastatic Thyroid Cancer

CE98: Targeting Radionuclide Therapy in Various Non-Malignant Arthritic Conditions Using Radiosynoviorthesis (RSO) (sponsored with WARMTH)

 

 

Membership Dues

Membership dues is $15 annually.

Member Benefits

Member benefits include:

 - Eligibility to vote in the Therapy COE Board of Directors elections

 - Newsletter

 - Sponsored educational symposia related to members’ interests

 - Therapy CoE E-Community

 - A $20.00 discount for Therapy CoE sponsored categorical session

 

Join The Therapy Center of Excellence 

- or -

Forward your request in writing with your check for annual center dues ($15) to SNMMI Membership Services, 1850 Samuel Morse Drive, Reston, VA 20190-5316. If you have any further questions about the Therapy Center of Excellence membership, please contact MemberInfo@snmmi.org



Announcements

2019 Saul Hertz, MD, Award

Deadline for submissions is October 15th!

 

Therapy Center of Excellence President

Dan Pryma, MD